Explainer 65 - Reviewing Michael Cannon's Book "Recovery"
Listen now
Description
In this RTP explainer episode 65, we are joined by Michael Cannon, Director of Health Policy Studies at the Cato Institute, and Christina Sandefur, Executive Vice President of the Goldwater Institute to discuss Michael Cannon’s new book, Recovery. Listen in as these experts consider the role of government agencies like the FDA in health spaces across America. "Recovery" discusses treatments approved by the FDA and the implications of approved drugs entering the market. Americans are inadvertently affected by the decisions of government agencies. With this said, "Recovery" argues the FDA takes away people’s rights to make their own health decisions. Does the FDA prohibit safe and effective drugs from entering the market? In this episode, experts discuss the implications of the decisions made by the FDA and the consequences of unsafe access to drugs. Copies of Michael Cannon’s book can be found at, https://www.cato.org/books/rec...
More Episodes
Federal regulators were busy in April 2024, with agencies publishing a record-breaking 66 significant new regulations; more than half of which had price tags higher than $200 million. This burst of regulatory activity can be attributed to a once obscure law known as the Congressional Review Act...
Published 09/04/24
Experts will examine the major questions doctrine, its role in regulatory litigation, and its place in administrative law in light of recent developments. Please register and join us for a live webinar on August 14, 2024 at 11 am EST. Featuring: Paul Ray, Director, Thomas A. Roe Institute for...
Published 08/21/24
Published 08/21/24